The board of directors of Luye Pharma Group Ltd., announced yesterday that the Company had entered into an agreement to...
Read moreGlaxoSmithKline's ViiV Healthcare has received marketing authorisation from the European Commission (EC) for its Triumeq (dolutegravir 50mg/abacavir 600mg/lamivudine 300mg) tablets...
Read moreCore Phase III clinical trial program complete; BIL showed consistent HbA1c superiority against comparators Lilly expects U.S. and European regulatory...
Read moreResearchers at UCC have developed a microneedle-based patch that results in increased vaccine-induced protection against malaria infection using lower doses...
Read moreLiverpool biotech firm Redx Pharma has signed a “transformational” multi-million pound deal with global pharmaceutical giant AstraZeneca to develop new...
Read moreCleveXel Pharma today announces that the company has entered into a new partnering agreement with Guilin Pharmaceutical, a Chinese company...
Read moreThe US Food and Drug Administration (FDA) has lifted a partial hold on patient enrolments for three Phase Ib clinical...
Read moreDenmark-based Novo Nordisk has introduced Ryzodeg (insulin degludec/insulin aspart) in Mexico, which will be used to treat adult patients suffering...
Read moreWockhardt Limited has announced a major boost to the New Drug Discovery program in Anti-Infective research when two of its...
Read moreToday at the European Society of Cardiology congress and published simultaneously in the New England Journal of Medicine, Novartis revealed...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.